Relationship Between Anti-HLA Antibodies and Coronary Allograft Vasculopathy after Heart Transplantation

被引:0
|
作者
Khandhar, S. J. [1 ]
Shullo, M. A. [2 ]
Zeevi, A. [3 ]
Toma, C. [1 ]
Teuteberg, J. J. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Heart & Vasc Inst, Pittsburgh, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源
关键词
D O I
10.1016/j.healun.2014.01.482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
475
引用
收藏
页码:S178 / S178
页数:1
相关论文
共 50 条
  • [41] CLINICAL SIGNIFICANCE OF DYNAMIC MONITORING OF ANTI-HLA AND ANTI-MICA ANTIBODIES AFTER RENAL TRANSPLANTATION AND SPECIFIC IMMUNOADSORPTION OF ANTI-HLA DR ANTIBODIES
    Hou, Quan Jian
    HUMAN IMMUNOLOGY, 2011, 72 : S88 - S88
  • [42] ASSOCIATION BETWEEN HLA AND THE PRODUCTION OF ANTI-HLA ANTIBODIES
    Pereira, Erica A.
    Saito, Patricia K.
    Yamakawa, Roger H.
    Borelli, Sueli D.
    HUMAN IMMUNOLOGY, 2012, 73 : 138 - 138
  • [43] COMPUTED TOMOGRAPHIC CORONARY ANGIOGRAPHY TO SCREEN FOR ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Panicker, M. G.
    Mitchell, A. G.
    Banner, N. R.
    Mittal, T. K.
    HEART, 2011, 97 : A64 - A64
  • [44] Computed Tomographic Coronary Angiography To Screen for Allograft Vasculopathy after Heart Transplantation
    Panicker, M. G.
    Mitchell, A. G.
    Banner, N. R.
    Mittal, T. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S49 - S50
  • [45] ST SEGMENT VARIABILITY IN CORONARY ALLOGRAFT VASCULOPATHY AFTER PEDIATRIC HEART TRANSPLANTATION
    Vu, Eric L.
    Andropoulos, Dean
    Dreyer, William
    Easley, R. B.
    Kibler, Kathy K.
    Rusin, Craig G.
    Brady, Ken M.
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 131 - 134
  • [46] influence of Reinnervation after Heart Transplantation on Coronary Allograft Vasculopathy and Cardiovascular Death
    Segovia, J.
    Barcelo, J. M.
    Gomez-Bueno, M.
    Gallego-Page, J. C.
    Cobo, M.
    Mirelis, J.
    Garcia-Pavia, P.
    Alonso, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S239 - S239
  • [47] Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease
    Reed, EF
    Hong, B
    Ho, E
    Harris, PE
    Weinberger, J
    SuciuFoca, N
    TRANSPLANTATION, 1996, 61 (04) : 566 - 572
  • [48] Elution of Anti-HLA Antibodies from Nephrectomies after Allograft Failure and Characterization of Eluted Antibodies.
    Kaneku, Hugo
    Wong, Waichi
    Everly, Matthew
    DeVito, Julie
    Porcheray, Fabrice
    Zorn, Emmanuel
    Terasaki, Paul I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 475 - 476
  • [49] IMMUNOGENICITY OF ANTI-HLA ANTIBODIES IN PANCREAS AND ISLET TRANSPLANTATION
    Chaigne, Benjamin
    Geneugelijk, Kirsten
    Bedat, Benoit
    Ahmed, Mohamed Alibashe
    Honger, Gideon
    de Seigneux, Sophie
    Demuylder-Mischler, Sandrine
    Berney, Thierry
    Spierings, Eric
    Ferrari-Lacraz, Sylvie
    Villard, Jean
    HLA, 2016, 87 (04) : 227 - 227
  • [50] The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation
    Chu, KE
    Ho, EK
    de la Torre, L
    Vasilescu, ER
    Marboe, CC
    CARDIOVASCULAR PATHOLOGY, 2005, 14 (04) : 219 - 224